Salinding, Kris Mae .

HRN: 22-09-95  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/15/2023
CEFUROXIME 500MG (TAB)
02/15/2023
02/22/2023
PO
500mg Tab
BID
Post NSVD With RMLE And Repair
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamReproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: